[HTML][HTML] Obesity: a chronic low-grade inflammation and its markers

D Khanna, S Khanna, P Khanna, P Kahar, BM Patel - Cureus, 2022 - ncbi.nlm.nih.gov
As the prevalence of obesity continues to rise, the world is facing a major public health
concern. Obesity is a complex disease associated with an increase in several inflammatory …

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

EE Calle, R Kaaks - Nature Reviews Cancer, 2004 - nature.com
The prevalence of obesity is rapidly increasing globally. Epidemiological studies have
associated obesity with a range of cancer types, although the mechanisms by which obesity …

Myocardial fatty acid metabolism in health and disease

GD Lopaschuk, JR Ussher, CDL Folmes… - Physiological …, 2010 - journals.physiology.org
There is a constant high demand for energy to sustain the continuous contractile activity of
the heart, which is met primarily by the β-oxidation of long-chain fatty acids. The control of …

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

KF Petersen, S Dufour, D Befroy… - … England Journal of …, 2004 - Mass Medical Soc
Background Insulin resistance appears to be the best predictor of the development of
diabetes in the children of patients with type 2 diabetes, but the mechanism responsible is …

Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases

L Recinella, G Orlando, C Ferrante… - Frontiers in …, 2020 - frontiersin.org
Besides its role as an energy storage organ, adipose tissue can be viewed as a dynamic
and complex endocrine organ, which produces and secretes several adipokines, including …

Obesity, metabolic syndrome, and cardiovascular disease

SM Grundy - The Journal of Clinical Endocrinology & …, 2004 - academic.oup.com
Obesity is rampant in the United States and is becoming increasing common worldwide. The
increase in obesity prevalence is due to two major factors, plentiful supplies of inexpensive …

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

A Xu, Y Wang, H Keshaw, LY Xu… - The Journal of …, 2003 - Am Soc Clin Investig
Adiponectin has recently been shown to be a promising candidate for the treatment of
obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in …

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

KF Petersen, S Dufour, D Befroy, M Lehrke… - Diabetes, 2005 - Am Diabetes Assoc
To examine the mechanism by which moderate weight reduction improves basal and insulin-
stimulated rates of glucose metabolism in patients with type 2 diabetes, we used 1H …

Obesity and insulin resistance: Pathophysiology and treatment

Y Tong, S Xu, L Huang, C Chen - Drug Discovery Today, 2022 - Elsevier
The prevalence of obesity is a major cause of many chronic metabolic disorders, including
type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and cancer. Insulin …

Regulation of Wnt signaling during adipogenesis

CN Bennett, SE Ross, KA Longo, L Bajnok… - Journal of Biological …, 2002 - ASBMB
We have identified Wnt10b as a potent inhibitor of adipogenesis that must be suppressed for
preadipocytes to differentiate in vitro. Here, we demonstrate that a specific inhibitor of …